| NCT ID | NCT05139589 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) |
| Condition | Endocarditis |
| Study Type | OBSERVATIONAL |
| Enrollment | 3,000 participants |
| Start Date | 2023-08-06 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 3,000 participants in total. It began in 2023-08-06 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The investigators will compare patients with and without infective ndocarditis undergoing valve surgery and evaluate factors that may help optimise perioperative care of these high-risk patients.
Eligibility Criteria
Inclusion Criteria: * Patients \> 18 years * Dutch or English speaking * All patients with infective endocarditis admitted to Amsterdam UMC in the study period * All patients with infective endocarditis scheduled for cardiac valve surgery compared to a matched cohort of patients scheduled for similar surgery due to non-infectious indication in Amsterdam UMC in the same period Exclusion Criteria: * Previous history of coagulation disorders
Contact & Investigator
Markus W Hollmann, MD,PhD,PhD
PRINCIPAL INVESTIGATOR
Amsterdam Academic Medical Center
Frequently Asked Questions
Who can join the NCT05139589 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Endocarditis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05139589 currently recruiting?
Yes, NCT05139589 is actively recruiting participants. Contact the research team at j.s.breel@amsterdamumc.nl for enrollment information.
Where is the NCT05139589 trial being conducted?
This trial is being conducted at Amsterdam, Netherlands.
Who is sponsoring the NCT05139589 clinical trial?
NCT05139589 is sponsored by Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA). The principal investigator is Markus W Hollmann, MD,PhD,PhD at Amsterdam Academic Medical Center. The trial plans to enroll 3,000 participants.